Trial Results

Protocol
Available Languages: English
Statistical Analysis Plan
Available Languages: English

A Study of ALXN1830 in Healthy Adult Participants

Study Identifier:
ALXN1830-HV-108
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Other

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: ALXN1830
  • Drug: Placebo
Date
Mar 2021 - Dec 2021
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 55 Years
Requirements Information
Sex
Female & Male
Age
18 - 55 Years

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: ALXN1830
  • Drug: Placebo
Date
Mar 2021 - Dec 2021
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 55 Years years
Requirements Information

Protocol Summary

This trial will study the effects of single and multiple doses of ALXN1830 in healthy adult participants.

Trial Locations

Location
Status
Location
Clinical Trial Site
Auckland, New Zealand
Status
N/A
Location
Research Site
Grafton, New Zealand, 1010
Status
N/A